Amphista Therapeutics
Pre-clinicalWe are purposefully designing the next generation of targeted protein degraders to transform the lives of patients with intractable diseases.
Founded
2017
Focus
OncologyImmunologyNeuroscience
About
We are purposefully designing the next generation of targeted protein degraders to transform the lives of patients with intractable diseases.
Funding History
2Total raised: $83M
Series B$53MForbionApr 15, 2022
Series A$30MNovartis Venture FundJan 15, 2020
Company Info
TypePrivate
Founded2017
LocationGlasgow, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile